Quantifying The Burden of Persistent Musculoskeletal Pain in Employees at Rolls-Royce in The United Kingdom: A Real-World Cross-Sectional Survey.
Journal
Journal of occupational and environmental medicine
ISSN: 1536-5948
Titre abrégé: J Occup Environ Med
Pays: United States
ID NLM: 9504688
Informations de publication
Date de publication:
01 06 2023
01 06 2023
Historique:
medline:
5
6
2023
pubmed:
29
3
2023
entrez:
28
3
2023
Statut:
ppublish
Résumé
We aimed to investigate the burden of persistent musculoskeletal (MSK) pain in Rolls-Royce UK employees. Employees with ( n = 298) and without ( n = 329) persistent MSK pain completed a cross-sectional survey. Weighted regression analyses were conducted to compare sickness absence, work ability, workplace accommodations/adaptations, and emotional well-being between these cohorts, controlling for confounders. Persistent MSK pain (particularly back pain) had a significant impact on physical work ability and was associated with increased sickness absence due to pain. Many employees (56%) had not disclosed their condition to their managers. Of these, 30% felt uncomfortable doing so, and 19% of employees reported insufficient support at work for their pain. These findings highlight the importance of creating a workplace culture that encourages the disclosure of work-relevant pain, enabling organizations to consider improved, tailored support for employees.
Identifiants
pubmed: 36977358
doi: 10.1097/JOM.0000000000002845
pii: 00043764-202306000-00021
pmc: PMC10227944
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e424-e434Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Occupational and Environmental Medicine.
Déclaration de conflit d'intérêts
Conflict of interest: L.A., R.R., and L.S.-R. are employees of Pfizer with stock and/or stock options. G.T.-S., L.M., and H.W. are employees of Adelphi Real World who are paid consultants to Pfizer in connection with this study. D.R. was an employee of and holds stock and/or stock options in Rolls-Royce. K.G. is an employee of and holds stock and/or stock options in Rolls-Royce. K.B. is an employee of the University of Huddersfield and is paid by Pfizer for his duties on the STAMPP Steering Committee.
Références
Scholz J. Finally, a systematic classification of pain (the ICD-11 ). Pract Pain Manag . 2019;19.
Blyth FM, Briggs AM, Schneider CH, et al. The global burden of musculoskeletal pain—where to from here? Am J Public Health . 2019;109:35–40.
Nicholas M, Vlaeyen JWS, Rief W, et al. The IASP classification of chronic pain for ICD-11 : chronic primary pain. Pain . 2019;160:28–37.
Hong JH, Kim HD, Shin HH, Huh B. Assessment of depression, anxiety, sleep disturbance, and quality of life in patients with chronic low back pain in Korea. Korean J Anesthesiol . 2014;66:444–450.
Roomes D, Abraham L, Russell R, et al. Quantifying the employer burden of persistent musculoskeletal pain at a large employer in the United Kingdom: a non-interventional, retrospective study of Rolls-Royce employee data. J Occup Environ Med . 2022;64:e145–e154.
Jin Z, Wang D, Zhang H, et al. Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the Global Burden of Disease Study 2017. Ann Rheum Dis . 2020;79:1014–1022.
Bevan S. Economic impact of musculoskeletal disorders (MSDs) on work in Europe. Best Pract Res Clin Rheumatol . 2015;29:356–373.
Vos T, Lim S, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet . 2020;396:1204–1222.
Institute for Health Metrics and Evaluation. Global Burden of Disease 2019. Available at: https://vizhub.healthdata.org/gbd-compare/ . Accessed March 21, 2022.
Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open . 2016;6:e010364.
National Institute for Health and Care Excellence (NICE). Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NICE guidelin NG193. 2021. Available at: https://www.nice.org.uk/guidance/ng193 . Accessed April 7, 2021.
Ali N, Qadery S, Narle G. Musculoskeletal Health: A 5 year strategic framework for prevention across the lifecourse. Department of Health and Social care working with Public Health England (PHE) and Department for Work and Pensions, 2019. PHE publications gateway number GW-477 . Available at: https://www.gov.uk/government/publications/musculoskeletal-health-5-year-prevention-strategic-framework . Accessed March 21, 2022.
Bayattork M, Jakobsen MD, Sundstrup E, Seidi F, Bay H, Andersen LL. Musculoskeletal pain in multiple body sites and work ability in the general working population: cross-sectional study among 10,000 wage earners. Scand J Pain . 2019;19:131–137. doi:10.1515/sjpain-2018-0304.
doi: 10.1515/sjpain-2018-0304
Ilmarinen J. Work ability—a comprehensive concept for occupational health research and prevention. Scand J Work Environ Health . 2009;35:1–5.
Vänni K, Virtanen P, Luukkaala T, Nygård CH. Relationship between perceived work ability and productivity loss. Int J Occup Saf Ergon . 2012;18:299–309.
Kinnunen U, Nätti J. Work ability score and future work ability as predictors of register-based disability pension and long-term sickness absence: a three-year follow-up study. Scand J Public Health . 2018;46:321–330.
Haukka E, Ojajärvi A, Kaila-Kangas L, Leino-Arjas P. Protective determinants of sickness absence among employees with multisite pain-a 7-year follow-up. Pain . 2017;158:220–229.
Pensola T, Haukka E, Kaila-Kangas L, Neupane S, Leino-Arjas P. Good work ability despite multisite musculoskeletal pain? A study among occupationally active Finns. Scand J Public Health . 2016;44:300–310.
Goetzel RZ, Henke RM, Head MA, Benevent R, Rhee K. Ten modifiable health risk factors and employees' medical costs—an update. Am J Health Promot . 2020;34:490–499.
Henke RM, Carls GS, Short ME, et al. The relationship between health risks and health and productivity costs among employees at Pepsi Bottling Group. J Occup Environ Med . 2010;52:519–527.
Dueñas M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res . 2016;9:457–467.
Public Health England. Musculoskeletal health: applying All Our Health. Public Health England: Office for Health Improvement and Disparities. 2022. Available at: https://www.gov.uk/government/publications/musculoskeletal-health-applying-all-our-health/musculoskeletal-health-applying-all-our-health . Accessed March 20, 2022
Tsuji T, Matsudaira K, Sato H, Vietri J, Jaffe DH. Association between presenteeism and health-related quality of life among Japanese adults with chronic lower back pain: a retrospective observational study. BMJ Open . 2018;8:e021160. doi:10.1136/bmjopen-2017-021160.
doi: 10.1136/bmjopen-2017-021160
Langley PC, Ruiz-Iban MA, Molina JT, de Andres J, Castellón JR. The prevalence, correlates and treatment of pain in Spain. J Med Econ . 2011;14:367–380.
Bergström G, Bodin L, Hagberg J, Aronsson G, Josephson M. Sickness presenteeism today, sickness absenteeism tomorrow? A prospective study on sickness presenteeism and future sickness absenteeism. J Occup Environ Med . 2009;51:629–638.
Royal College of Physicians (RCP). The diagnosis of fibromyalgia syndrome. UK Clinical Guidelines . London: RCP; 2022.
Kendall NAS, Burton AK, Main CJ, et al. Tackling musculoskeletal problems: a guide for the clinic and workplace—identifying obstacles using the psychosocial flags framework . London: The Stationery Office; 2009.
Coyne KS, Currie BM, Donevan S, et al. Psychometric validation of the electronic chronic pain questions (eCPQ) in a primary care setting. Curr Med Res Opin . 2017;33:137–148.
Fullen B, Morlion B, Linton SJ, et al. Management of chronic low back pain and the impact on patients' personal and professional lives: results from an international patient survey. Pain Pract . 2022;22:463–477. doi:10.1111/papr.13103.
doi: 10.1111/papr.13103
Ahlstrom L, Grimby-Ekman A, Hagberg M, Dellve L. The work ability index and single-item question: associations with sick leave, symptoms, and health—a prospective study of women on long-term sick leave. Scand J Work Environ Health . 2010;36:404–412.
Palmlöf L, Skillgate E, Talbäck M, Josephson M, Vingård E, Holm LW. Poor work ability increases sickness absence over 10 years. Occup Med . 2019;69:359–365.
Elo AL, Leppänen A, Jahkola A. Validity of a single-item measure of stress symptoms. Scand J Work Environ Health. 2003; 29: 444–451.
Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med . 2015;34:3661–3679.
ISPE. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf . 2008;17:200–208.
EphMRA. European Pharmaceutical Market Research Association (EphMRA) Code of Conduct 2019. Available at: http://www.ephmra.org/Code-of-Conduct-Support . Accessed March 16, 2022.
Berger ML, Sox H, Willke RJ, et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the Joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Value Health . 2017;20:1003–1008. doi:10.1016/j.jval.2017.08.3019.
doi: 10.1016/j.jval.2017.08.3019
Love D. Global burden of chronic musculoskeletal pain in the workplace. 2018. Available at: https://ihpm.org/wp-content/uploads/2020/05/ChronicPain_2018_Pfizer_IHPM.pdf . Accessed March 16, 2022.
Coenen P, Gouttebarge V, van der Burght AS, et al. The effect of lifting during work on low back pain: a health impact assessment based on a meta-analysis. Occup Environ Med . 2014;71:871–877.
Skovlund SV, Bláfoss R, Sundstrup E, Andersen LL. Association between physical work demands and work ability in workers with musculoskeletal pain: cross-sectional study. BMC Musculoskelet Disord . 2020;21:166.
Hannerz H, Holtermann A, Madsen IEH. Musculoskeletal pain as a predictor for depression in the general working population of Denmark. Scand J Public Health . 2021;49:589–597.
Peterson S, Piercy J, Blackburn S, Sullivan E, Karyekar CS, Li N. The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis. BMC Rheumatol . 2019;3:43.
Straub LE, Cisternas MG. Psychological well-being among US adults with arthritis and the unmet need for mental health care. Open Access Rheumatol . 2017;9:101–110.
Deady M, Collins DAJ, Johnston DA, et al. The impact of depression, anxiety and comorbidity on occupational outcomes. Occup Med . 2022;72:17–24.
Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med . 2008;70:890–897.
Werner EL, Cote P. Low back pain and determinants of sickness absence. Eur J Gen Pract . 2009;15:74–79.
Burdorf A. Prevention strategies for sickness absence: sick individuals or sick populations? Scand J Work Environ Health . 2019;45:101–102.
Health and Safety Executive. Work related musculoskeletal disorder statistics (WRMSDs) in Great Britain. 2021. Available at: https://www.hse.gov.uk/statistics/causdis/msd.pdf . Accessed March 16, 2022
Battisti WP, Wager E, Baltzer L, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med . 2015;163:461–464.